Slice cultures from head and neck squamous cell carcinoma: a novel test system for drug susceptibility and mechanisms of resistance

@article{Gerlach2014SliceCF,
  title={Slice cultures from head and neck squamous cell carcinoma: a novel test system for drug susceptibility and mechanisms of resistance},
  author={M. Gerlach and F. Merz and G. Wichmann and C. Kubick and C. Wittekind and F. Lordick and A. Dietz and I. Bechmann},
  journal={British Journal of Cancer},
  year={2014},
  volume={110},
  pages={479 - 488}
}
  • M. Gerlach, F. Merz, +5 authors I. Bechmann
  • Published 2014
  • Medicine
  • British Journal of Cancer
  • Background:Human head and neck squamous cell carcinoma (HNSCC) fundamentally vary in their susceptibility to different cytotoxic drugs and treatment modalities. There is at present no clinically accepted test system to predict the most effective therapy for an individual patient.Methods:Therefore, we established tumour-derived slice cultures which can be kept in vitro for at least 6 days. Upon treatment with cisplatin, docetaxel and cetuximab, slices were fixed and paraffin sections were cut… CONTINUE READING

    Figures, Tables, and Topics from this paper.

    Organotypic slice cultures of human gastric and esophagogastric junction cancer
    28
    Feasibility of Primary Tumor Culture Models and Preclinical Prediction Assays for Head and Neck Cancer: A Narrative Review
    8
    Individual Susceptibility Analysis Using Patient‐derived Slice Cultures of Colorectal Carcinoma
    6
    Precision Cut Cancer Tissue Slices in Anti-Cancer Drug Testing -
    13
    Tumor slice culture system to assess drug response of primary breast cancer
    62

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 54 REFERENCES
    Heterogeneity of epithelial and stromal cells of head and neck squamous cell carcinomas in ex vivo chemoresponse
    11
    Organotypic slice cultures of human glioblastoma reveal different susceptibilities to treatments
    67
    [Pharmacological characterization of head and neck cancer in ex-vivo tests].
    1
    Personalized Chemotherapy Profiling Using Cancer Cell Lines from Selectable Mice
    25
    The practicalities of using tissue slices as preclinical organotypic breast cancer models
    40